Daily as of 3 Nov 16:00 ET
- Price
- between the two $154.97 vs 50 $156.14 / 200 $141.93
- Projection
- No cross projected
- Test
- No active test
- Last cross
- ๐จGolden cross 2 Sep 2025 ยท projected 20 bars out
State Street SPDR S&P Biotech ETF (XBI) is an AMEX-listed ETF that Cruxta has tracked for 50/200 crosses since 2018.
The 50 SMA has sat above the 200 on the daily since Sep 2025, with no cross projected inside the 30 bars Cruxta tracks. On both the weekly and the 4-hour, price sits above the 50 and the 200; on the daily it is between the two.
| Crossed | Direction | Timeframe | Projected | Cross test |
|---|---|---|---|---|
| 23 Oct 2026 | ๐Death | 4-hour | 22 bars out | 2 bar cross test |
| 2 Sep 2025 | ๐จGolden moderate | daily | 20 bars out | Not tested |
| 2 Jul 2025 | ๐จGolden | 4-hour | 22 bars out | โ |
| 21 Jan 2025 | ๐Death | daily | 18 bars out | 3 bar cross test |
| week of 13 Jan 2025 | ๐จGolden flat | weekly | 29 bars out | 4 bar cross test |
Cruxta · 50/200 moving-average crosses on US equities. Recorded crosses are observations. Projected crosses are projections, not advice.